ABT vs OLED · P/E 25, rev $44.33B vs P/E 33, rev $647.7M
Abbott Laboratories (ABT) versus Universal Display (OLED) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Universal Display (OLED) is a electronic components company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported OLED revenue for 2024-12-31 was $647.7M. Net income was $222.1M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. OLED currently screens at market cap $7.49B and trailing P/E 32.8.
Not investment advice. Open the ABT and OLED stock pages for the full models.
Not investment advice.